Discretamine is primarily studied for its potential pharmacological properties, particularly in the field of neuroscience and medicine. It has shown promise as an acetylcholinesterase inhibitor, which could make it useful in treating neurodegenerative diseases like Alzheimer's by enhancing cognitive function and memory. Additionally, discretamine has been investigated for its antioxidant properties, which may help in reducing oxidative stress-related damage in cells. Research also suggests its potential as an anti-inflammatory agent, offering possibilities for managing chronic inflammatory conditions. Further studies are ongoing to explore its efficacy and safety in therapeutic applications.